Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-044980
Filing Date
2013-09-19
Accepted
2013-09-19 21:04:32
Documents
1
Period of Report
2013-09-17

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c599187_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c599187_4x0.xml 4 5746
  Complete submission text file 0001209191-13-044980.txt   7302
Mailing Address 8001 ARISTA PLACE SUITE 430 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 430 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 8001 ARISTA PLACE, STE 200 BROOMFIELD CO 80021
Business Address
Wheeler Patrick M (Reporting) CIK: 0001478297 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22873 | Film No.: 131106585